MicroVue™ DPD EIA

The MicroVue DPD EIA offers a laboratory test that measures deoxypyridinoline cross-links (Dpd).


Product Specifications

Citations 15
Specimen

Urine 50 μL

LLOQ 3 nmol/L
ULOQ 300 nmol/L
Assay Time 3 hours
Cross Reactivity

Baboon, Cow, Cynomolgous monkey, Dog, Guinea pig, Horse, Mouse, Pig, Rabbit, Rat, Rhesus monkey, Sheep, Squirrel monkey

Ordering Information

For In Vitro Diagnostic Use.
Catalog Number 8007
Catalog Number (CE)  
Size 96 wells/test
Price (USD) $995.00
Price (EURO) 700,00 €

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

The MicroVue DPD EIA offers a laboratory test that measures deoxypyridinoline cross-links (Dpd).

Size 96 wells/test
Form

96 well plate with 12 eight-well strips in a resealable foil pouch

Specimen Urine 50 μL
Limit of Detection (LOD) 1.1 nmol/L
Lower Limit of Quantitation (LLOQ) 3 nmol/L
Upper Limit of Quantitation (ULOQ) 300 nmol/L
Intra Assay 4.3–8.4%
Inter Assay 3.1–4.8%
Standards 6
Controls 2
Sample Values

Females (Ages 25–44) 3.0–7.4 nmol DPD/nmol Creatinine, Males (Ages 25–55) 2.3–5.4 nmol DPD/nmol Creatinine

Assay Time 3 hours
Cross Reactivity

Baboon, Cow, Cynomolgous monkey, Dog, Guinea pig, Horse, Mouse, Pig, Rabbit, Rat, Rhesus monkey, Sheep, Squirrel monkey

Storage

Store unopened kit between 2°C to 8°C. Refer to manual for storing individual components

Background

DPD is a specific marker of bone resorption which is excreted in the urine. MicroVue DPD EIA provides a quantitative measure of deoxypyridinoline (Dpd), a cross-link of bone type 1 collagen released during the resorption process. Dpd is excreted unmetabolized in urine. Elevated levels of urinary Dpd indicate elevated bone resorption in individuals. MicroVue DPD is a urinary assay that provides a quantitative measure of the excretion of deoxypyridinoline (DPD) crosslinks as an indicator of bone resorption. Elevated levels of urinary DPD indicate elevated bone resorption in individuals. Measurement of DPD is intended for use as an aid in monitoring bone resorption changes in postmenopausal women receiving hormonal or bisphosphonate antiresorptive therapies and in individuals diagnosed with osteoporosis.